Fundrise's Public Venture Fund Collides With Reality

The premium problem

VCX listed on the New York Stock Exchange on March 19 with a net asset value (NAV) of $18.97 per share. Within days, speculative demand drove the price above $575: a premium of roughly 2,930 percent over the fund's stated NAV. That premium reflected no change in the underlying portfolio. The fund's top holdings (Anthropic at 21 percent, Databricks at 18 percent, OpenAI at 10 percent, Anduril at 7 percent, SpaceX at 5 percent) did not announce earnings, raise new rounds, or undergo any material revaluation during that period.

Jack Shannon, equity strategies principal at Morningstar, told Yahoo Finance: "With the implied valuations when you have this premium, your upside is gone." He added that VCX might attract hype and heavy short-term trading, but for long-term investors, "it's a very risky bet at today's price."

Even at Friday's closing price of approximately $166, VCX trades at roughly 775 percent above its listing NAV. The premium has compressed dramatically, but it has not disappeared.

Citron and the short thesis

The selloff accelerated after Citron Research disclosed a short position on Thursday, raising regulatory concerns tied to past SEC charges against Fundrise Advisors LLC. Citron noted that Fundrise's advisory arm faced SEC charges in 2023 over paid solicitation practices and urged regulators to examine whether the firm is currently compensating influencers or publishers to promote VCX.

Fundrise CEO Ben Miller appeared on CNBC Friday to push back: "Some companies short stock and then do PR smear campaign to drive the stock down. Making up nonsense, throwing mud against the wall. That is totally relevant. But trying to talk down the stock, that hurt our investors."

Citron rejected the characterization, stating that its criticism is "grounded in simple financial logic." The exchange illustrates a familiar dynamic: the short seller argues the math doesn't work, the CEO argues the mission matters. The market, for now, is siding with the math.

Structural risks

The fund's architecture creates risks that do not exist in traditional ETFs or closed-end funds holding public equities.

First, liquidity mismatch: VCX holds positions in private companies that cannot be quickly sold. If redemption pressure builds, the fund cannot liquidate its Anthropic or SpaceX stakes on a secondary market with the same ease that a Vanguard fund sells Apple shares. This asymmetry between the liquidity of the wrapper (a publicly traded NYSE security) and the illiquidity of the contents (private venture stakes) is the core structural tension.

Second, lockup risk: VCX has a six-month lockup for early investors. When that lockup expires, a wave of selling could create additional downward pressure. The fund launched with over 100,000 investors and approximately $650 million in net assets.

Third, competition risk: VCX's premium exists in part because it is one of the few ways retail investors can access private AI companies. That scarcity is temporary. When any of these companies go public, or when competing funds launch (Destiny Tech100, Robinhood Ventures, and others are already trading), VCX's exclusivity erodes.

To be sure, the fund's underlying thesis is not without merit. Many of the most valuable technology companies are staying private longer, and retail investors have historically been locked out of pre-IPO wealth creation. Miller has argued that "everyday investors are missing out" and that VCX is "designed to solve that problem." The fund's reported one-year return of 63.27 percent (as of January 31, 2026, based on NAV appreciation) suggests the portfolio itself has performed well.

But a good portfolio and a good stock are not the same thing. The distance between VCX's market price and its NAV is not a measure of the portfolio's quality; it is a measure of speculative demand for the wrapper. And that demand is proving fragile.

The tokenization layer

Adding complexity, Fundrise announced a partnership with xStocks (powered by Kraken parent company Payward) on March 27 to tokenize VCX, creating an onchain asset called VCXx. The tokenized version would allow global investors to gain exposure to the fund and enable "collateralization, lending, and integration into automated onchain strategies."

The timing is notable: the announcement came on the same day VCX fell more than 30 percent. Whether tokenization expands legitimate access or simply adds another speculative layer to an already volatile instrument is an open question. The xStocks tokens are not available to U.S. persons, which means the tokenized version serves a different investor base than the NYSE-listed shares.

What comes next

VCX is down 71 percent from its all-time high in five trading days. The fund charges an annual management fee of 1.85 percent, has no analyst coverage, and trades with no earnings, no revenue, and no traditional valuation metrics. Its price is determined entirely by supply, demand, and sentiment.

The near-term catalysts are identifiable: the lockup expiration (roughly September 2026), potential IPOs of portfolio companies (OpenAI and Databricks are widely expected to go public), and whether regulators respond to Citron's request for scrutiny. If one of the top holdings files for an IPO, VCX's premium could compress further as investors gain direct access to the underlying companies.

The fund's 431 percent total return since inception (per Yahoo Finance) is extraordinary. But nearly all of that return reflects the premium expansion that is now violently reversing. For investors who bought at $575, the question is not whether Anthropic and SpaceX are good companies. They almost certainly are. The question is whether paying 30 times NAV for illiquid exposure to those companies, wrapped in a volatile public vehicle with a 1.85 percent fee, was ever a sound proposition. The market is delivering its answer.